Baidu
map
LIFE SCI 润色咨询

LIFE SCIENCES

出版年份：1973 年文章数：7314 投稿命中率： 开通期刊会员，数据随心看

出版周期：Weekly 自引率：2.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2228407, encodeId=d0e3222840e80, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：缺氧损伤<br>经验分享：一篇文章2+月被接了，这文章期初redox biology外审被拒，建议转投FREE RADICAL BIOLOGY AND MEDICINE，到了FREE RADICAL BIOLOGY大修审稿人提了一个很不专业的问题，我battle了一下，被审稿人拒了，编辑建议转这个杂志。<br>Received at Editorial Office 16 Jul 2024<br>Under review 18 Jul 2024<br>RRC 14 Aug 2024<br>RC 16 Aug 2024<br>Major revision 20 Aug 2024<br>Revision Article revised 17 Sep 2024<br>Under review 18 Sep 2024<br>RRC 24 Sep 2024<br>RC 25 Sep 2024<br>Article accepted for publication 27 Sep 2024 <br>看了下上面的文章，不算很水，但是和7分左右杂志差距明显，只要文章数据量够大，速度很快的，我们组中过3篇了，都是数据量大，做的机制不新，分子机制不够细致的内容，都是3个月左右，相反有做的数据量不大，内容创新的，反而没被接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1702011203, createdName=dmsx'311, createdTime=Sun Sep 29 18:25:16 CST 2024, time=2024-09-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231047, encodeId=10a5223104edb, content=偏重的研究方向：细胞生物学<br>经验分享：10.02号投的稿，现在还是submitted，请问要不要催一下，催了又害怕被拒，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Tue Oct 15 15:26:25 CST 2024, time=2024-10-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2231411, encodeId=6cbf2231411cb, content=偏重的研究方向：糖尿病<br>经验分享：10月6投稿还是Submitted to Journal。太慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Thu Oct 17 18:24:47 CST 2024, time=2024-10-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学<br>经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2228717, encodeId=a40f2228e1797, content=偏重的研究方向：肿瘤学<br>经验分享：再投一篇，9.17投稿，9.29送审，继续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Oct 01 15:39:38 CST 2024, time=2024-10-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2225491, encodeId=1e4222254918c, content=为啥最近投稿一直显示submitted to journal啊，看之前就是拒稿也很快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538b9172922, createdName=ms6000000004860619, createdTime=Thu Sep 12 22:54:39 CST 2024, time=2024-09-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2228229, encodeId=7dc12228229b4, content=Sep 23 2024 submit to the journal<br>Sep 27 2024， Decision in Process<br> 这是审稿流程，还是要直接拒掉啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Sat Sep 28 18:07:13 CST 2024, time=2024-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2217395, encodeId=9bf1221e39580, content=投稿2个星期了 为什么还在submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e39a9383599, createdName=ms5000000518147486, createdTime=Mon Jul 29 15:02:26 CST 2024, time=2024-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219704, encodeId=b45a2219e0430, content=有最近投稿的吗？分享下经验吧，为什么我8.2投稿，一周多了还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=341c5620475, createdName=ms6000002077160867, createdTime=Mon Aug 12 11:59:43 CST 2024, time=2024-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224447, encodeId=2684222444e50, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：with editor 之后，decision in process 是什么意思啊，大家都有这个过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b85598979, createdName=ms4000000146382330, createdTime=Fri Sep 06 14:56:37 CST 2024, time=2024-09-06, status=1, ipAttribution=河南省)]
    2024-09-29 dmsx'311 来自重庆

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向：缺氧损伤
    经验分享：一篇文章2+月被接了，这文章期初redox biology外审被拒，建议转投FREE RADICAL BIOLOGY AND MEDICINE，到了FREE RADICAL BIOLOGY大修审稿人提了一个很不专业的问题，我battle了一下，被审稿人拒了，编辑建议转这个杂志。
    Received at Editorial Office 16 Jul 2024
    Under review 18 Jul 2024
    RRC 14 Aug 2024
    RC 16 Aug 2024
    Major revision 20 Aug 2024
    Revision Article revised 17 Sep 2024
    Under review 18 Sep 2024
    RRC 24 Sep 2024
    RC 25 Sep 2024
    Article accepted for publication 27 Sep 2024
    看了下上面的文章，不算很水，但是和7分左右杂志差距明显，只要文章数据量够大，速度很快的，我们组中过3篇了，都是数据量大，做的机制不新，分子机制不够细致的内容，都是3个月左右，相反有做的数据量不大，内容创新的，反而没被接。

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2228407, encodeId=d0e3222840e80, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：缺氧损伤<br>经验分享：一篇文章2+月被接了，这文章期初redox biology外审被拒，建议转投FREE RADICAL BIOLOGY AND MEDICINE，到了FREE RADICAL BIOLOGY大修审稿人提了一个很不专业的问题，我battle了一下，被审稿人拒了，编辑建议转这个杂志。<br>Received at Editorial Office 16 Jul 2024<br>Under review 18 Jul 2024<br>RRC 14 Aug 2024<br>RC 16 Aug 2024<br>Major revision 20 Aug 2024<br>Revision Article revised 17 Sep 2024<br>Under review 18 Sep 2024<br>RRC 24 Sep 2024<br>RC 25 Sep 2024<br>Article accepted for publication 27 Sep 2024 <br>看了下上面的文章，不算很水，但是和7分左右杂志差距明显，只要文章数据量够大，速度很快的，我们组中过3篇了，都是数据量大，做的机制不新，分子机制不够细致的内容，都是3个月左右，相反有做的数据量不大，内容创新的，反而没被接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1702011203, createdName=dmsx'311, createdTime=Sun Sep 29 18:25:16 CST 2024, time=2024-09-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231047, encodeId=10a5223104edb, content=偏重的研究方向：细胞生物学<br>经验分享：10.02号投的稿，现在还是submitted，请问要不要催一下，催了又害怕被拒，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Tue Oct 15 15:26:25 CST 2024, time=2024-10-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2231411, encodeId=6cbf2231411cb, content=偏重的研究方向：糖尿病<br>经验分享：10月6投稿还是Submitted to Journal。太慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Thu Oct 17 18:24:47 CST 2024, time=2024-10-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学<br>经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2228717, encodeId=a40f2228e1797, content=偏重的研究方向：肿瘤学<br>经验分享：再投一篇，9.17投稿，9.29送审，继续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Oct 01 15:39:38 CST 2024, time=2024-10-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2225491, encodeId=1e4222254918c, content=为啥最近投稿一直显示submitted to journal啊，看之前就是拒稿也很快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538b9172922, createdName=ms6000000004860619, createdTime=Thu Sep 12 22:54:39 CST 2024, time=2024-09-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2228229, encodeId=7dc12228229b4, content=Sep 23 2024 submit to the journal<br>Sep 27 2024， Decision in Process<br> 这是审稿流程，还是要直接拒掉啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Sat Sep 28 18:07:13 CST 2024, time=2024-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2217395, encodeId=9bf1221e39580, content=投稿2个星期了 为什么还在submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e39a9383599, createdName=ms5000000518147486, createdTime=Mon Jul 29 15:02:26 CST 2024, time=2024-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219704, encodeId=b45a2219e0430, content=有最近投稿的吗？分享下经验吧，为什么我8.2投稿，一周多了还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=341c5620475, createdName=ms6000002077160867, createdTime=Mon Aug 12 11:59:43 CST 2024, time=2024-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224447, encodeId=2684222444e50, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：with editor 之后，decision in process 是什么意思啊，大家都有这个过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b85598979, createdName=ms4000000146382330, createdTime=Fri Sep 06 14:56:37 CST 2024, time=2024-09-06, status=1, ipAttribution=河南省)]
    2024-10-15 ms9000000976333684 来自浙江省

    偏重的研究方向：细胞生物学
    经验分享：10.02号投的稿，现在还是submitted，请问要不要催一下，催了又害怕被拒，着急毕业

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2228407, encodeId=d0e3222840e80, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：缺氧损伤<br>经验分享：一篇文章2+月被接了，这文章期初redox biology外审被拒，建议转投FREE RADICAL BIOLOGY AND MEDICINE，到了FREE RADICAL BIOLOGY大修审稿人提了一个很不专业的问题，我battle了一下，被审稿人拒了，编辑建议转这个杂志。<br>Received at Editorial Office 16 Jul 2024<br>Under review 18 Jul 2024<br>RRC 14 Aug 2024<br>RC 16 Aug 2024<br>Major revision 20 Aug 2024<br>Revision Article revised 17 Sep 2024<br>Under review 18 Sep 2024<br>RRC 24 Sep 2024<br>RC 25 Sep 2024<br>Article accepted for publication 27 Sep 2024 <br>看了下上面的文章，不算很水，但是和7分左右杂志差距明显，只要文章数据量够大，速度很快的，我们组中过3篇了，都是数据量大，做的机制不新，分子机制不够细致的内容，都是3个月左右，相反有做的数据量不大，内容创新的，反而没被接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1702011203, createdName=dmsx'311, createdTime=Sun Sep 29 18:25:16 CST 2024, time=2024-09-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231047, encodeId=10a5223104edb, content=偏重的研究方向：细胞生物学<br>经验分享：10.02号投的稿，现在还是submitted，请问要不要催一下，催了又害怕被拒，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Tue Oct 15 15:26:25 CST 2024, time=2024-10-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2231411, encodeId=6cbf2231411cb, content=偏重的研究方向：糖尿病<br>经验分享：10月6投稿还是Submitted to Journal。太慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Thu Oct 17 18:24:47 CST 2024, time=2024-10-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学<br>经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2228717, encodeId=a40f2228e1797, content=偏重的研究方向：肿瘤学<br>经验分享：再投一篇，9.17投稿，9.29送审，继续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Oct 01 15:39:38 CST 2024, time=2024-10-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2225491, encodeId=1e4222254918c, content=为啥最近投稿一直显示submitted to journal啊，看之前就是拒稿也很快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538b9172922, createdName=ms6000000004860619, createdTime=Thu Sep 12 22:54:39 CST 2024, time=2024-09-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2228229, encodeId=7dc12228229b4, content=Sep 23 2024 submit to the journal<br>Sep 27 2024， Decision in Process<br> 这是审稿流程，还是要直接拒掉啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Sat Sep 28 18:07:13 CST 2024, time=2024-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2217395, encodeId=9bf1221e39580, content=投稿2个星期了 为什么还在submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e39a9383599, createdName=ms5000000518147486, createdTime=Mon Jul 29 15:02:26 CST 2024, time=2024-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219704, encodeId=b45a2219e0430, content=有最近投稿的吗？分享下经验吧，为什么我8.2投稿，一周多了还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=341c5620475, createdName=ms6000002077160867, createdTime=Mon Aug 12 11:59:43 CST 2024, time=2024-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224447, encodeId=2684222444e50, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：with editor 之后，decision in process 是什么意思啊，大家都有这个过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b85598979, createdName=ms4000000146382330, createdTime=Fri Sep 06 14:56:37 CST 2024, time=2024-09-06, status=1, ipAttribution=河南省)]
    2024-10-17 1258c620m14暂无昵称 来自北京

    偏重的研究方向：糖尿病
    经验分享：10月6投稿还是Submitted to Journal。太慢了。

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2228407, encodeId=d0e3222840e80, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：缺氧损伤<br>经验分享：一篇文章2+月被接了，这文章期初redox biology外审被拒，建议转投FREE RADICAL BIOLOGY AND MEDICINE，到了FREE RADICAL BIOLOGY大修审稿人提了一个很不专业的问题，我battle了一下，被审稿人拒了，编辑建议转这个杂志。<br>Received at Editorial Office 16 Jul 2024<br>Under review 18 Jul 2024<br>RRC 14 Aug 2024<br>RC 16 Aug 2024<br>Major revision 20 Aug 2024<br>Revision Article revised 17 Sep 2024<br>Under review 18 Sep 2024<br>RRC 24 Sep 2024<br>RC 25 Sep 2024<br>Article accepted for publication 27 Sep 2024 <br>看了下上面的文章，不算很水，但是和7分左右杂志差距明显，只要文章数据量够大，速度很快的，我们组中过3篇了，都是数据量大，做的机制不新，分子机制不够细致的内容，都是3个月左右，相反有做的数据量不大，内容创新的，反而没被接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1702011203, createdName=dmsx'311, createdTime=Sun Sep 29 18:25:16 CST 2024, time=2024-09-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231047, encodeId=10a5223104edb, content=偏重的研究方向：细胞生物学<br>经验分享：10.02号投的稿，现在还是submitted，请问要不要催一下，催了又害怕被拒，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Tue Oct 15 15:26:25 CST 2024, time=2024-10-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2231411, encodeId=6cbf2231411cb, content=偏重的研究方向：糖尿病<br>经验分享：10月6投稿还是Submitted to Journal。太慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Thu Oct 17 18:24:47 CST 2024, time=2024-10-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学<br>经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2228717, encodeId=a40f2228e1797, content=偏重的研究方向：肿瘤学<br>经验分享：再投一篇，9.17投稿，9.29送审，继续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Oct 01 15:39:38 CST 2024, time=2024-10-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2225491, encodeId=1e4222254918c, content=为啥最近投稿一直显示submitted to journal啊，看之前就是拒稿也很快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538b9172922, createdName=ms6000000004860619, createdTime=Thu Sep 12 22:54:39 CST 2024, time=2024-09-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2228229, encodeId=7dc12228229b4, content=Sep 23 2024 submit to the journal<br>Sep 27 2024， Decision in Process<br> 这是审稿流程，还是要直接拒掉啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Sat Sep 28 18:07:13 CST 2024, time=2024-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2217395, encodeId=9bf1221e39580, content=投稿2个星期了 为什么还在submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e39a9383599, createdName=ms5000000518147486, createdTime=Mon Jul 29 15:02:26 CST 2024, time=2024-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219704, encodeId=b45a2219e0430, content=有最近投稿的吗？分享下经验吧，为什么我8.2投稿，一周多了还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=341c5620475, createdName=ms6000002077160867, createdTime=Mon Aug 12 11:59:43 CST 2024, time=2024-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224447, encodeId=2684222444e50, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：with editor 之后，decision in process 是什么意思啊，大家都有这个过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b85598979, createdName=ms4000000146382330, createdTime=Fri Sep 06 14:56:37 CST 2024, time=2024-09-06, status=1, ipAttribution=河南省)]
    2024-01-30 1489114dm38(暂无昵称) 来自四川省

    偏重的研究方向：肿瘤学
    经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿

    16

    展开16条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2228407, encodeId=d0e3222840e80, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：缺氧损伤<br>经验分享：一篇文章2+月被接了，这文章期初redox biology外审被拒，建议转投FREE RADICAL BIOLOGY AND MEDICINE，到了FREE RADICAL BIOLOGY大修审稿人提了一个很不专业的问题，我battle了一下，被审稿人拒了，编辑建议转这个杂志。<br>Received at Editorial Office 16 Jul 2024<br>Under review 18 Jul 2024<br>RRC 14 Aug 2024<br>RC 16 Aug 2024<br>Major revision 20 Aug 2024<br>Revision Article revised 17 Sep 2024<br>Under review 18 Sep 2024<br>RRC 24 Sep 2024<br>RC 25 Sep 2024<br>Article accepted for publication 27 Sep 2024 <br>看了下上面的文章，不算很水，但是和7分左右杂志差距明显，只要文章数据量够大，速度很快的，我们组中过3篇了，都是数据量大，做的机制不新，分子机制不够细致的内容，都是3个月左右，相反有做的数据量不大，内容创新的，反而没被接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1702011203, createdName=dmsx'311, createdTime=Sun Sep 29 18:25:16 CST 2024, time=2024-09-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231047, encodeId=10a5223104edb, content=偏重的研究方向：细胞生物学<br>经验分享：10.02号投的稿，现在还是submitted，请问要不要催一下，催了又害怕被拒，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Tue Oct 15 15:26:25 CST 2024, time=2024-10-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2231411, encodeId=6cbf2231411cb, content=偏重的研究方向：糖尿病<br>经验分享：10月6投稿还是Submitted to Journal。太慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Thu Oct 17 18:24:47 CST 2024, time=2024-10-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学<br>经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2228717, encodeId=a40f2228e1797, content=偏重的研究方向：肿瘤学<br>经验分享：再投一篇，9.17投稿，9.29送审，继续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Oct 01 15:39:38 CST 2024, time=2024-10-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2225491, encodeId=1e4222254918c, content=为啥最近投稿一直显示submitted to journal啊，看之前就是拒稿也很快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538b9172922, createdName=ms6000000004860619, createdTime=Thu Sep 12 22:54:39 CST 2024, time=2024-09-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2228229, encodeId=7dc12228229b4, content=Sep 23 2024 submit to the journal<br>Sep 27 2024， Decision in Process<br> 这是审稿流程，还是要直接拒掉啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Sat Sep 28 18:07:13 CST 2024, time=2024-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2217395, encodeId=9bf1221e39580, content=投稿2个星期了 为什么还在submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e39a9383599, createdName=ms5000000518147486, createdTime=Mon Jul 29 15:02:26 CST 2024, time=2024-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219704, encodeId=b45a2219e0430, content=有最近投稿的吗？分享下经验吧，为什么我8.2投稿，一周多了还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=341c5620475, createdName=ms6000002077160867, createdTime=Mon Aug 12 11:59:43 CST 2024, time=2024-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224447, encodeId=2684222444e50, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：with editor 之后，decision in process 是什么意思啊，大家都有这个过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b85598979, createdName=ms4000000146382330, createdTime=Fri Sep 06 14:56:37 CST 2024, time=2024-09-06, status=1, ipAttribution=河南省)]
    2024-10-01 1489114dm38(暂无昵称) 来自四川省

    偏重的研究方向：肿瘤学
    经验分享：再投一篇，9.17投稿，9.29送审，继续更新

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2228407, encodeId=d0e3222840e80, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：缺氧损伤<br>经验分享：一篇文章2+月被接了，这文章期初redox biology外审被拒，建议转投FREE RADICAL BIOLOGY AND MEDICINE，到了FREE RADICAL BIOLOGY大修审稿人提了一个很不专业的问题，我battle了一下，被审稿人拒了，编辑建议转这个杂志。<br>Received at Editorial Office 16 Jul 2024<br>Under review 18 Jul 2024<br>RRC 14 Aug 2024<br>RC 16 Aug 2024<br>Major revision 20 Aug 2024<br>Revision Article revised 17 Sep 2024<br>Under review 18 Sep 2024<br>RRC 24 Sep 2024<br>RC 25 Sep 2024<br>Article accepted for publication 27 Sep 2024 <br>看了下上面的文章，不算很水，但是和7分左右杂志差距明显，只要文章数据量够大，速度很快的，我们组中过3篇了，都是数据量大，做的机制不新，分子机制不够细致的内容，都是3个月左右，相反有做的数据量不大，内容创新的，反而没被接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1702011203, createdName=dmsx'311, createdTime=Sun Sep 29 18:25:16 CST 2024, time=2024-09-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231047, encodeId=10a5223104edb, content=偏重的研究方向：细胞生物学<br>经验分享：10.02号投的稿，现在还是submitted，请问要不要催一下，催了又害怕被拒，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Tue Oct 15 15:26:25 CST 2024, time=2024-10-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2231411, encodeId=6cbf2231411cb, content=偏重的研究方向：糖尿病<br>经验分享：10月6投稿还是Submitted to Journal。太慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Thu Oct 17 18:24:47 CST 2024, time=2024-10-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学<br>经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2228717, encodeId=a40f2228e1797, content=偏重的研究方向：肿瘤学<br>经验分享：再投一篇，9.17投稿，9.29送审，继续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Oct 01 15:39:38 CST 2024, time=2024-10-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2225491, encodeId=1e4222254918c, content=为啥最近投稿一直显示submitted to journal啊，看之前就是拒稿也很快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538b9172922, createdName=ms6000000004860619, createdTime=Thu Sep 12 22:54:39 CST 2024, time=2024-09-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2228229, encodeId=7dc12228229b4, content=Sep 23 2024 submit to the journal<br>Sep 27 2024， Decision in Process<br> 这是审稿流程，还是要直接拒掉啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Sat Sep 28 18:07:13 CST 2024, time=2024-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2217395, encodeId=9bf1221e39580, content=投稿2个星期了 为什么还在submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e39a9383599, createdName=ms5000000518147486, createdTime=Mon Jul 29 15:02:26 CST 2024, time=2024-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219704, encodeId=b45a2219e0430, content=有最近投稿的吗？分享下经验吧，为什么我8.2投稿，一周多了还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=341c5620475, createdName=ms6000002077160867, createdTime=Mon Aug 12 11:59:43 CST 2024, time=2024-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224447, encodeId=2684222444e50, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：with editor 之后，decision in process 是什么意思啊，大家都有这个过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b85598979, createdName=ms4000000146382330, createdTime=Fri Sep 06 14:56:37 CST 2024, time=2024-09-06, status=1, ipAttribution=河南省)]
    2024-09-12 ms6000000004860619 来自广西

    为啥最近投稿一直显示submitted to journal啊，看之前就是拒稿也很快的呀

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2228407, encodeId=d0e3222840e80, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：缺氧损伤<br>经验分享：一篇文章2+月被接了，这文章期初redox biology外审被拒，建议转投FREE RADICAL BIOLOGY AND MEDICINE，到了FREE RADICAL BIOLOGY大修审稿人提了一个很不专业的问题，我battle了一下，被审稿人拒了，编辑建议转这个杂志。<br>Received at Editorial Office 16 Jul 2024<br>Under review 18 Jul 2024<br>RRC 14 Aug 2024<br>RC 16 Aug 2024<br>Major revision 20 Aug 2024<br>Revision Article revised 17 Sep 2024<br>Under review 18 Sep 2024<br>RRC 24 Sep 2024<br>RC 25 Sep 2024<br>Article accepted for publication 27 Sep 2024 <br>看了下上面的文章，不算很水，但是和7分左右杂志差距明显，只要文章数据量够大，速度很快的，我们组中过3篇了，都是数据量大，做的机制不新，分子机制不够细致的内容，都是3个月左右，相反有做的数据量不大，内容创新的，反而没被接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1702011203, createdName=dmsx'311, createdTime=Sun Sep 29 18:25:16 CST 2024, time=2024-09-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231047, encodeId=10a5223104edb, content=偏重的研究方向：细胞生物学<br>经验分享：10.02号投的稿，现在还是submitted，请问要不要催一下，催了又害怕被拒，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Tue Oct 15 15:26:25 CST 2024, time=2024-10-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2231411, encodeId=6cbf2231411cb, content=偏重的研究方向：糖尿病<br>经验分享：10月6投稿还是Submitted to Journal。太慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Thu Oct 17 18:24:47 CST 2024, time=2024-10-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学<br>经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2228717, encodeId=a40f2228e1797, content=偏重的研究方向：肿瘤学<br>经验分享：再投一篇，9.17投稿，9.29送审，继续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Oct 01 15:39:38 CST 2024, time=2024-10-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2225491, encodeId=1e4222254918c, content=为啥最近投稿一直显示submitted to journal啊，看之前就是拒稿也很快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538b9172922, createdName=ms6000000004860619, createdTime=Thu Sep 12 22:54:39 CST 2024, time=2024-09-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2228229, encodeId=7dc12228229b4, content=Sep 23 2024 submit to the journal<br>Sep 27 2024， Decision in Process<br> 这是审稿流程，还是要直接拒掉啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Sat Sep 28 18:07:13 CST 2024, time=2024-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2217395, encodeId=9bf1221e39580, content=投稿2个星期了 为什么还在submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e39a9383599, createdName=ms5000000518147486, createdTime=Mon Jul 29 15:02:26 CST 2024, time=2024-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219704, encodeId=b45a2219e0430, content=有最近投稿的吗？分享下经验吧，为什么我8.2投稿，一周多了还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=341c5620475, createdName=ms6000002077160867, createdTime=Mon Aug 12 11:59:43 CST 2024, time=2024-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224447, encodeId=2684222444e50, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：with editor 之后，decision in process 是什么意思啊，大家都有这个过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b85598979, createdName=ms4000000146382330, createdTime=Fri Sep 06 14:56:37 CST 2024, time=2024-09-06, status=1, ipAttribution=河南省)]
    2024-09-28 ms3000000983513178 来自湖北省

    Sep 23 2024 submit to the journal
    Sep 27 2024， Decision in Process
    这是审稿流程，还是要直接拒掉啊

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2228407, encodeId=d0e3222840e80, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：缺氧损伤<br>经验分享：一篇文章2+月被接了，这文章期初redox biology外审被拒，建议转投FREE RADICAL BIOLOGY AND MEDICINE，到了FREE RADICAL BIOLOGY大修审稿人提了一个很不专业的问题，我battle了一下，被审稿人拒了，编辑建议转这个杂志。<br>Received at Editorial Office 16 Jul 2024<br>Under review 18 Jul 2024<br>RRC 14 Aug 2024<br>RC 16 Aug 2024<br>Major revision 20 Aug 2024<br>Revision Article revised 17 Sep 2024<br>Under review 18 Sep 2024<br>RRC 24 Sep 2024<br>RC 25 Sep 2024<br>Article accepted for publication 27 Sep 2024 <br>看了下上面的文章，不算很水，但是和7分左右杂志差距明显，只要文章数据量够大，速度很快的，我们组中过3篇了，都是数据量大，做的机制不新，分子机制不够细致的内容，都是3个月左右，相反有做的数据量不大，内容创新的，反而没被接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1702011203, createdName=dmsx'311, createdTime=Sun Sep 29 18:25:16 CST 2024, time=2024-09-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231047, encodeId=10a5223104edb, content=偏重的研究方向：细胞生物学<br>经验分享：10.02号投的稿，现在还是submitted，请问要不要催一下，催了又害怕被拒，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Tue Oct 15 15:26:25 CST 2024, time=2024-10-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2231411, encodeId=6cbf2231411cb, content=偏重的研究方向：糖尿病<br>经验分享：10月6投稿还是Submitted to Journal。太慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Thu Oct 17 18:24:47 CST 2024, time=2024-10-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学<br>经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2228717, encodeId=a40f2228e1797, content=偏重的研究方向：肿瘤学<br>经验分享：再投一篇，9.17投稿，9.29送审，继续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Oct 01 15:39:38 CST 2024, time=2024-10-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2225491, encodeId=1e4222254918c, content=为啥最近投稿一直显示submitted to journal啊，看之前就是拒稿也很快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538b9172922, createdName=ms6000000004860619, createdTime=Thu Sep 12 22:54:39 CST 2024, time=2024-09-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2228229, encodeId=7dc12228229b4, content=Sep 23 2024 submit to the journal<br>Sep 27 2024， Decision in Process<br> 这是审稿流程，还是要直接拒掉啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Sat Sep 28 18:07:13 CST 2024, time=2024-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2217395, encodeId=9bf1221e39580, content=投稿2个星期了 为什么还在submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e39a9383599, createdName=ms5000000518147486, createdTime=Mon Jul 29 15:02:26 CST 2024, time=2024-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219704, encodeId=b45a2219e0430, content=有最近投稿的吗？分享下经验吧，为什么我8.2投稿，一周多了还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=341c5620475, createdName=ms6000002077160867, createdTime=Mon Aug 12 11:59:43 CST 2024, time=2024-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224447, encodeId=2684222444e50, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：with editor 之后，decision in process 是什么意思啊，大家都有这个过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b85598979, createdName=ms4000000146382330, createdTime=Fri Sep 06 14:56:37 CST 2024, time=2024-09-06, status=1, ipAttribution=河南省)]
    2024-07-29 ms5000000518147486

    投稿2个星期了 为什么还在submitted to journal

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2228407, encodeId=d0e3222840e80, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：缺氧损伤<br>经验分享：一篇文章2+月被接了，这文章期初redox biology外审被拒，建议转投FREE RADICAL BIOLOGY AND MEDICINE，到了FREE RADICAL BIOLOGY大修审稿人提了一个很不专业的问题，我battle了一下，被审稿人拒了，编辑建议转这个杂志。<br>Received at Editorial Office 16 Jul 2024<br>Under review 18 Jul 2024<br>RRC 14 Aug 2024<br>RC 16 Aug 2024<br>Major revision 20 Aug 2024<br>Revision Article revised 17 Sep 2024<br>Under review 18 Sep 2024<br>RRC 24 Sep 2024<br>RC 25 Sep 2024<br>Article accepted for publication 27 Sep 2024 <br>看了下上面的文章，不算很水，但是和7分左右杂志差距明显，只要文章数据量够大，速度很快的，我们组中过3篇了，都是数据量大，做的机制不新，分子机制不够细致的内容，都是3个月左右，相反有做的数据量不大，内容创新的，反而没被接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1702011203, createdName=dmsx'311, createdTime=Sun Sep 29 18:25:16 CST 2024, time=2024-09-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231047, encodeId=10a5223104edb, content=偏重的研究方向：细胞生物学<br>经验分享：10.02号投的稿，现在还是submitted，请问要不要催一下，催了又害怕被拒，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Tue Oct 15 15:26:25 CST 2024, time=2024-10-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2231411, encodeId=6cbf2231411cb, content=偏重的研究方向：糖尿病<br>经验分享：10月6投稿还是Submitted to Journal。太慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Thu Oct 17 18:24:47 CST 2024, time=2024-10-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学<br>经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2228717, encodeId=a40f2228e1797, content=偏重的研究方向：肿瘤学<br>经验分享：再投一篇，9.17投稿，9.29送审，继续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Oct 01 15:39:38 CST 2024, time=2024-10-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2225491, encodeId=1e4222254918c, content=为啥最近投稿一直显示submitted to journal啊，看之前就是拒稿也很快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538b9172922, createdName=ms6000000004860619, createdTime=Thu Sep 12 22:54:39 CST 2024, time=2024-09-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2228229, encodeId=7dc12228229b4, content=Sep 23 2024 submit to the journal<br>Sep 27 2024， Decision in Process<br> 这是审稿流程，还是要直接拒掉啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Sat Sep 28 18:07:13 CST 2024, time=2024-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2217395, encodeId=9bf1221e39580, content=投稿2个星期了 为什么还在submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e39a9383599, createdName=ms5000000518147486, createdTime=Mon Jul 29 15:02:26 CST 2024, time=2024-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219704, encodeId=b45a2219e0430, content=有最近投稿的吗？分享下经验吧，为什么我8.2投稿，一周多了还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=341c5620475, createdName=ms6000002077160867, createdTime=Mon Aug 12 11:59:43 CST 2024, time=2024-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224447, encodeId=2684222444e50, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：with editor 之后，decision in process 是什么意思啊，大家都有这个过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b85598979, createdName=ms4000000146382330, createdTime=Fri Sep 06 14:56:37 CST 2024, time=2024-09-06, status=1, ipAttribution=河南省)]
    2024-08-12 ms6000002077160867 来自上海

    有最近投稿的吗？分享下经验吧，为什么我8.2投稿，一周多了还是submit to journal

    8

    展开8条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2228407, encodeId=d0e3222840e80, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：缺氧损伤<br>经验分享：一篇文章2+月被接了，这文章期初redox biology外审被拒，建议转投FREE RADICAL BIOLOGY AND MEDICINE，到了FREE RADICAL BIOLOGY大修审稿人提了一个很不专业的问题，我battle了一下，被审稿人拒了，编辑建议转这个杂志。<br>Received at Editorial Office 16 Jul 2024<br>Under review 18 Jul 2024<br>RRC 14 Aug 2024<br>RC 16 Aug 2024<br>Major revision 20 Aug 2024<br>Revision Article revised 17 Sep 2024<br>Under review 18 Sep 2024<br>RRC 24 Sep 2024<br>RC 25 Sep 2024<br>Article accepted for publication 27 Sep 2024 <br>看了下上面的文章，不算很水，但是和7分左右杂志差距明显，只要文章数据量够大，速度很快的，我们组中过3篇了，都是数据量大，做的机制不新，分子机制不够细致的内容，都是3个月左右，相反有做的数据量不大，内容创新的，反而没被接。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1702011203, createdName=dmsx'311, createdTime=Sun Sep 29 18:25:16 CST 2024, time=2024-09-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2231047, encodeId=10a5223104edb, content=偏重的研究方向：细胞生物学<br>经验分享：10.02号投的稿，现在还是submitted，请问要不要催一下，催了又害怕被拒，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Tue Oct 15 15:26:25 CST 2024, time=2024-10-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2231411, encodeId=6cbf2231411cb, content=偏重的研究方向：糖尿病<br>经验分享：10月6投稿还是Submitted to Journal。太慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eaf52573934, createdName=1258c620m14暂无昵称, createdTime=Thu Oct 17 18:24:47 CST 2024, time=2024-10-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学<br>经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2228717, encodeId=a40f2228e1797, content=偏重的研究方向：肿瘤学<br>经验分享：再投一篇，9.17投稿，9.29送审，继续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Oct 01 15:39:38 CST 2024, time=2024-10-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2225491, encodeId=1e4222254918c, content=为啥最近投稿一直显示submitted to journal啊，看之前就是拒稿也很快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538b9172922, createdName=ms6000000004860619, createdTime=Thu Sep 12 22:54:39 CST 2024, time=2024-09-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2228229, encodeId=7dc12228229b4, content=Sep 23 2024 submit to the journal<br>Sep 27 2024， Decision in Process<br> 这是审稿流程，还是要直接拒掉啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Sat Sep 28 18:07:13 CST 2024, time=2024-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2217395, encodeId=9bf1221e39580, content=投稿2个星期了 为什么还在submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e39a9383599, createdName=ms5000000518147486, createdTime=Mon Jul 29 15:02:26 CST 2024, time=2024-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2219704, encodeId=b45a2219e0430, content=有最近投稿的吗？分享下经验吧，为什么我8.2投稿，一周多了还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=341c5620475, createdName=ms6000002077160867, createdTime=Mon Aug 12 11:59:43 CST 2024, time=2024-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2224447, encodeId=2684222444e50, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：with editor 之后，decision in process 是什么意思啊，大家都有这个过程吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49b85598979, createdName=ms4000000146382330, createdTime=Fri Sep 06 14:56:37 CST 2024, time=2024-09-06, status=1, ipAttribution=河南省)]
    2024-09-06 ms4000000146382330 来自河南省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤
    经验分享：with editor 之后，decision in process 是什么意思啊，大家都有这个过程吗

    2

    展开2条回复
共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map